FDA proposes allowing sunscreen ingredient already used in Europe and Asia [MSNBC.com]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: MSNBC.com
Dec. 11, 2025, 8:00 AM ESTByMustafa FattahThe Food and Drug Administration announced a proposal Thursday to make another sunscreen ingredient available to U.S. manufacturers.The ingredient —a UV light filter called bemotrizinolSo, why all the hype around a sunscreen ingredient?UV filters do the job of blocking out harmful ultraviolet rays from the sun. To be most effective, they need to be “broad-spectrum,” meaning they block out both UVA and UVB rays.“The ‘B’ is ‘burning rays,’ which causes sunburn. The ‘A’ is the ‘aging ray,’ which causes tanning reaction, wrinkle formation,” said Dr. Henry Lim, former chair of dermatology at Henry Ford in Detroit and past president of the American Academy of Dermatology. Both, he added, contribute toskin cancerThere are two main types of UV filters used in sunscreens: chemical and mineral. Mineral sunscreens — which contain zinc oxide or titanium dioxide — can block both UVA and UVB rays, but often leave a white cast on the skin, making chemical f
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Zealand Pharma and OTR to develop metabolic disease therapeutics [Yahoo! Finance]Yahoo! Finance
- Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry's broadest in vitro diagnostic menu [Yahoo! Finance]Yahoo! Finance
- Genentech's Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer [Yahoo! Finance]Yahoo! Finance
- Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast CancerBusiness Wire
- Roche (OTCMKTS:RHHBY) had its "buy" rating reaffirmed by analysts at HSBC Holdings plc.MarketBeat